Immuneering (IMRX) Reports 86% 9-Month Survival in Pancreatic Cancer
Immuneering Corporation (NASDAQ:IMRX) is a clinical-stage oncology company headquartered in Cambridge, Massachusetts, that is pioneering a new class…
Qualigen Therapeutics (QLGN) Secures $41M Faraday Future Deal
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) is a clinical-stage biotechnology company based in Carlsbad, California, with a mission to develop…
BriaCell (BCTX) Raises $13.8M to Advance Cancer Immunotherapy Pipeline
BriaCell Therapeutics Corp. (NASDAQ:BCTX) is a clinical-stage biotechnology company advancing novel immunotherapies designed to transform cancer treatment. Founded…
PepGen (PEPG) Soars 96.8% After Breakthrough DM1 Results
PepGen Inc. (NASDAQ:PEPG) is a clinical-stage biotechnology company pioneering transformative therapies for neuromuscular and neurological diseases. Founded in…
Acadia Healthcare (ACHC) Down 71% in a Year
Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the largest dedicated providers of behavioral health services in the…
Soleno (SLNO) Oversold After 26% Drop
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies…
Acadia Pharmaceuticals (ACAD)’s Phase 3 Trial Fails
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company headquartered in San Diego, California, dedicated to advancing treatments for…
Cidara (CDTX) Soars on $516.9M Cash War Chest
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company dedicated to the discovery, development, and commercialization of novel anti-infectives…
FibroGen (FGEN) Sells China Arm to AstraZeneca in $160M Deal
FibroGen Inc. (NASDAQ:FGEN) is a biopharmaceutical company founded in 1993 and headquartered in San Francisco, California, with a…
Flora Growth (FLGC) Soars 69% After $401M AI Pivot
Flora Growth Corp. (NASDAQ:FLGC) is a diversified international company that was originally built around natural wellness, cannabis-derived products,…
Zymeworks (ZYME) Reports 153% Revenue Growth, Beats EPS Expectations
Zymeworks Inc. (NASDAQ:ZYME) is a clinical-stage biotechnology company that has built its reputation on innovation in the field…
Metsera (MTSR) Shares Soar on Pfizer’s $7.3B Buyout
Metsera Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical company founded in 2022 with a focus on developing next-generation therapies…
Quantum BioPharma (QNTM) Eyes $250M in Royalties From Unbuzzd Wellness Deal
Quantum BioPharma Ltd. (NASDAQ:QNTM) is a biopharmaceutical company committed to developing innovative therapeutic assets that address some of…
Analysts See 127% Upside for Intellia (NTLA) After $14.99 Surge
Intellia Therapeutics Inc. (NASDAQ:NTLA) is a pioneering genome editing company founded in 2014 with the mission to develop…
Oscar Health (OSCR) Reports $2.86B Revenue in Q2 2025
Oscar Health Inc. (NYSE:OSCR) is a technology-driven health insurance company founded in 2012 with the mission of making…
UnitedHealth (UNH)’s Q3 Earnings Forecast Crashes Nearly 60%
UnitedHealth Group Incorporated (NYSE:UNH) is one of the largest and most influential health care companies in the United…
Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the…
Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss
Trulieve Cannabis Corp. (OTC:TCNNF) is one of the largest and most established multi-state cannabis operators in the United…